Panjang
Black Swan - Delta Variant

Idea for COVID-19:
- Delta variant now 20% of US cases says CDC, up from 3% 4 weeks ago.
- Technicals suggest new wave to begin.
Forecast: 54 Million+ by EOY.
bloomberg.com/news/articles/2021-06-23/delta-variant-seen-in-a-fifth-of-u-s-covid-cases-cdc-says
New variant selection timeframe matched as forecasted previously:

GLHF
- DPT
- Delta variant now 20% of US cases says CDC, up from 3% 4 weeks ago.
- Technicals suggest new wave to begin.
Forecast: 54 Million+ by EOY.
bloomberg.com/news/articles/2021-06-23/delta-variant-seen-in-a-fifth-of-u-s-covid-cases-cdc-says
New variant selection timeframe matched as forecasted previously:

GLHF
- DPT
Dagangan aktif
"The resurgence in both hospitalisations and deaths is dominated by those that have received two doses of the vaccine, comprising around 60% and 70% of the wave respectively."p.10, para 32.
gov.uk/government/publications/spi-m-o-summary-of-further-modelling-of-easing-restrictions-roadmap-step-2-31-march-2021
Dagangan aktif
It does appear that markets are being set up for a big drop coinciding with a Delta variant news drop to cause maximum panicDagangan aktif
Disbelief in Delta variant and COVID resurgence due to low deaths, but the death curve takes 2-3 weeks to follow the confirmed cases curve. Now it begins - COVID Wave 3.Dagangan aktif
How come UK opens lockdowns when Delta variant spiking, while they are 90%~ vaccinated?I will tell you a secret:
I speculate that the effective treatment is albumin (a-la Spanish Flu). However, for treatment to be effective, they need convalescent blood plasma (recovered patients), which is why restrictions are being lifted so that more plasma may be harvested.
It is the worst imaginable time to open, so I imagine that the people at the top are scared.

Dagangan aktif
Confirmed cases are exceeding my expectations, but should reach a peak in acceleration in the fall and rise with slowing growth until the target is hit EOY.Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.